Equities

Neurocrine Biosciences Inc

Neurocrine Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)125.65
  • Today's Change0.65 / 0.52%
  • Shares traded1.21m
  • 1 Year change+13.22%
  • Beta0.3354
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,8871,4891,134
OPERATING EXPENSES
Cost of revenue total402314
Selling, general and admin. expenses, total888751583
Depreciation/amortization------
Unusual expense(income)14472105
Other operating expenses, total------
Total operating expense1,6361,3101,031
Operating income251179103
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes332214101
Provision for income taxes825912
Net income after taxes25015590
Minority interest------
Net income before extra. Items25015590
Total extraordinary items------
Net income25015590
Inc.avail. to common excl. extra. Items25015590
Inc.avail. to common incl. extra. Items25015590
EPS RECONCILIATION
Basic/primary weighted average shares989695
Basic/primary eps excl. extra items2.561.610.95
Basic/primary eps incl. extra items2.561.610.95
Dilution adjustment------
Diluted weighted average shares1019998
Diluted eps excl. extra items2.471.560.92
Diluted eps incl. extra items2.471.560.92
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental4.607.1026
SUPPLEMENTAL INCOME
Depreciation, supplemental181511
Total special items14472105
NORMALISED INCOME
Normalized income before taxes476286207
Effect of special items on income taxes02012
Income tax excluding impact of special items827924
Normalized income after tax394206183
Normalized income avail. to common394206183
Basic normalized EPS4.032.151.93
Diluted normalized EPS3.902.091.87
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.